Letters: GLP-1 medicines work best alongside lifestyle adjustments, writes Dr Sam Robson. Plus letters from Anne Williams, Siân Williams, and a reader who has had success with Mounjaro ...
Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping cessation trials. SEATTLE an ...
Achieve Life Sciences, Inc. has submitted a New Drug Application (NDA) to the U.S. FDA for cytisinicline, which, if approved, would be the first new pharmacotherapy for nicotine dependence in 20 years ...
Hosted on MSN
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
(The Conversation) – A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He ...
Nicotine e-cigarettes have been found to be more effective than traditional methods in helping adults quit smoking, with quit ...
A new analysis of existing studies co-led by a University of Massachusetts Amherst public health researcher finds that ...
People taking GLP-1 drugs often talk about “food noise” vanishing: the constant mental chatter about food that dominated thei ...
SEATTLE and VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company focused on the global development and ...
Rutgers‑led study of 2.2 million people finds addiction risk is driven more by genes tied to impulse control and reward ...
Laura Oyler’s syndicated column “The Truth About Nicotine” in the Oct. 7 Albuquerque Journal argued for loosening regulations on noncombustible nicotine (e-cigarettes and nicotine pouches) because ...
Helping smokers quit is important. What's more important, though, is making sure youth don't get addicted to nicotine in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results